Should we ban B6 supplementation of INH therapy in childhood tuberculosis? | IMSEAR

Main content 1 Search 2 Footer 3

+A A -A High contrast

Should we ban B6 supplementation of INH therapy in childhood tuberculosis?

Mathur, G P; Mathur, S; Rastogi, S.

Article in En | IMSEAR | ID: sea-80823

Subject(s)

Child; Developing Countries; Drug Therapy, Combination; Humans; Isoniazid/administration & dosage; Peripheral Nervous System Diseases/chemically induced; Protein-Energy Malnutrition/drug therapy; Pyridoxine/administration & dosage; Rifampin/administration & dosage; Risk Factors; Tuberculosis, Pulmonary/drug therapy; Vitamin B 6 Deficiency/chemically induced

Search on Google

Full text: 1 Index: IMSEAR Main subject: Pyridoxine / Vitamin B 6 Deficiency / Rifampin / Tuberculosis, Pulmonary / Humans / Child / Risk Factors / Protein-Energy Malnutrition / Peripheral Nervous System Diseases / Developing Countries Type of study: Etiology_studies / Risk_factors_studies Language: En Year: 1993 Type: Article

Search on Google

Full text: 1 Index: IMSEAR Main subject: Pyridoxine / Vitamin B 6 Deficiency / Rifampin / Tuberculosis, Pulmonary / Humans / Child / Risk Factors / Protein-Energy Malnutrition / Peripheral Nervous System Diseases / Developing Countries Type of study: Etiology_studies / Risk_factors_studies Language: En Year: 1993 Type: Article